儿童滑动气管成形术长期结局:227例单中心回顾性分析
该研究回顾性分析了2001至2023年单中心227例接受滑动气管成形术(STP)的儿童患者,其中53%为婴儿、54%合并先天性心脏病。术后5年和10年免于气管成形翻修率分别为95%和91%,住院、5年和10年生存率分别为93%、88%和86%。多因素回归显示单功能肺、先心病、术后气管内支架置入、气管造口依赖、气管裂开及ECMO使用与术后死亡显著相关。
要点
- STP术后长期生存良好,5年和10年生存率分别为88%和86%。
- 单功能肺、先心病及术后ECMO、气管裂开等显著增加死亡风险。
- 术后5年和10年免于气管成形翻修率分别为95%和91%。
核心结论
- 儿童滑动气管成形术可获得良好的长期生存和较低的翻修率。
- 单功能肺、先心病及术后气管内支架、气管造口依赖、气管裂开和ECMO使用与术后死亡显著相关。
研究设计与样本
- 回顾性单中心队列研究,纳入2001至2023年接受胸部滑动气管成形术的连续患者227例。
- 手术在体外循环(CPB)或体外膜肺氧合(ECMO)下进行。
主要发现
- 227例中婴儿120例(53%),合并先心病122例(54%),单功能肺32例(14%)。
- 术前48例(21%)已插管,44例(19%)曾接受心脏手术,34例(15%)曾在外院行气管成形术需翻修。
- 术中212例(93%)使用CPB灌注,15例在ECMO下手术,78例(34%)同期行心脏修复。
- 术后94例(42%)在24小时内早期拔管;院内并发症包括气管裂开5%(n=12)和气道感染23%(n=53)。
- 再干预包括再插管19%(n=44)、气管内支架置入8%(n=18)、气管造口依赖5%(n=11)和新ECMO置管4%(n=10)。
关键数值与推荐
- 5年和10年免于气管成形翻修率分别为95%和91%。
- 住院、5年和10年生存率分别为93%、88%和86%。
临床怎么用
- 对于合并单功能肺、先心病或需ECMO支持的患儿,应充分评估STP术后死亡风险。
- 术后需密切监测气管裂开、气道感染和气管内支架置入等并发症,及时干预。
- 早期拔管(≤24小时)在部分患儿中可行,但需结合个体情况决策。
局限性
- 回顾性单中心研究,结果外推需谨慎。
- 原文未报告多中心验证或长期功能状态数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Literature on the slide tracheoplasty (STP) is primarily limited to small institutional experiences. Therefore, the authors analyzed their large institutional experience with STP. METHODS: All consecutive patients who underwent thoracic STP on cardiopulmonary bypass (CPB) or extracorporeal membrane oxygenation (ECMO) at the authors' institution from 2001 to 2023 were retrospectively reviewed. RESULTS: Two hundred twenty-seven patients, including 120 (53%) infants and 122 (54%) with congenital heart disease (CHD), were identified. Thirty-two (14%) patients had a single functional lung (SFL). Preoperatively, 44 (19%) patients underwent ≥1 cardiac surgery and 34 (15%) had prior tracheoplasties at outside hospitals requiring revision. Forty-eight (21%) patients were intubated pre-STP. Intraoperatively, 212 (93%) patients underwent CPB perfusion (15 STPs were performed on ECMO), and 78 (34%) patients underwent concomitant cardiac repair. Postoperatively, 94 (42%) patients were extubated early (≤24 hours). In-hospital complications included tracheal dehiscence (5%, n = 12) and airway infection (23%, n = 53). Reinterventions included reintubation (19%, n = 44), endotracheal stent (ETS) placement (8%, n = 18), tracheostomy dependence (5%, n = 11), and novel ECMO cannulation (4%, n = 10). The 5- and 10-year freedom from tracheoplasty revision was 95% and 91%, respectively. Upon multivariable regression, factors significantly (P < .05) associated with postoperative mortality included: SFL (hazard ratio [HR], = 5.14; CI, = 1.73-15.29; P = .003), CHD (HR, = 4.34; CI, = 1.45-12.93; P = .009), postoperative ETS placement (HR, = 3.79; CI, = 1.21-11.87; P = .022), postoperative tracheostomy dependence (HR, = 9.54; CI, = 2.86-31.81; P < .001), postoperative tracheal dehiscence (HR, = 6.48; CI, = 1.17-35.81; P = .032), ECMO from pre- through post-STP (HR, = 6.39; CI, = 1.44-28.31; P = .015), and novel postoperative ECMO (HR, = 20.70; CI, = 5.22-82.09; P < .001). Overall, the in-hospital, 5-, and 10-year survivals were 93%, 88%, and 86%, respectively. CONCLUSIONS: Tracheal anomalies present a complex physiologic state with limited reports on outcomes and associated perioperative factors. The present series, the largest institutional experience in the United States to date, demonstrates that excellent long-term outcomes following STP are achievable.
引用
- Hogue SJ, Mehdizadeh-Shrifi A, Turner D, et al. Long-term outcomes of children undergoing slide tracheoplasty: An institutional review of 227 patients. J Thorac Cardiovasc Surg. 2026. PMID: 42641781. doi:10.1016/j.jtcvs.2026.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。